Storia in 4 fonti

Kardigan extends biotech’s streak of big IPOs with $400M haul

Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 mese fa

Kardigan extends biotech’s streak of big IPOs with $400M haul

Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.

originale

Timeline cronologica

mercoledì 17 giugno 2026·biopharmadive.com
Kardigan extends biotech’s streak of big IPOs with $400M haul
Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to…
giovedì 18 giugno 2026·morningstar.com
Kardigan Announces Pricing of Upsized Initial Public Offering
Kardigan Announces Pricing of Upsized Initial Public Offering

Kardigan extends biotech’s streak of big IPOs with $400M haul

Confronto fonti

Kardigan extends biotech’s streak of big IPOs with $400M haul

Timeline cronologica

Kardigan extends biotech’s streak of big IPOs with $400M haul

Kardigan Announces Pricing of Upsized Initial Public Offering

Kardigan raises $400M in IPO to back three clinical-stage cardio drugs

Kardigan raises $400M in upsized US IPO, pricing at top of range

Kardigan Announces Pricing of Upsized Initial Public Offering

Kardigan raises $400M in IPO to back three clinical-stage cardio drugs

Kardigan raises $400M in upsized US IPO, pricing at top of range